Perle Bioscience
About:
Perle Bioscience is a developer of peptide therapies for the generation of new insulin producing cells.
Website: http://perlebioscience.com
Twitter/X: perlebioscience
Description:
Perle is setting the stage for usage of a new proprietary peptide therapy for generation of new insulin producing cells, which is a breakthrough with the potential to benefit millions of people.
Total Funding Amount:
$2M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Atlanta, Georgia, United States
Founded Date:
2013-05-18
Contact Email:
ClaresaLevetanMD(AT)PerleBioscience.com
Founders:
Claresa Levetan
Number of Employees:
11-50
Last Funding Date:
2013-09-26
IPO Status:
Private
Industries:
© 2025 bioDAO.ai